https://www.selleckchem.com/pr....oducts/SB-525334.htm
AAA in a selected patient population, in both elective and emergency settings. Long term outcomes are acceptable although inferior to CMDs. Mid and long term outcomes emphasise the p-Branch as a possible endovascular treatment for juxtarenal aortic pathology where CMD is not an option. Further innovation to address target vessel complications is needed, as these seem more prevalent than after repair with CMDs. Since 2012, the Centers for Disease Control and Prevention has conducted the national Tips From Former Smokers® public educati
Curtir
Comentario
Compartilhar
